C19 Notes

Recent Posts

Recent Posts

Pages: 1 ... 5 6 7 8 9 10
61
C19 Notes Database / Re: Vaccines Problems and reasons
« Last post by stog on November 29, 2020, 09:20:46 AM »
This vaccine tag search is very good for overview of all interim vaccine trials as they come through.

https://www.sciencemediacentre.org/tag/vaccines/
62
C19 Notes Database / Lateral Flow Test LFD Accuracy
« Last post by stog on November 26, 2020, 09:08:48 AM »
Scientists urge caution on use of lateral flow tests to screen for Covid-19
useful info here for anyone picking up students from Uni returning home for Christmas who are taking LFD tests -- lateral flow tests.
use only as a guide. a sensible approach from my brother in Law who has both sets of elderly parents coming for Xmas is that both sets need to properly isolate for a week before coming, thus protecting all and reducing risk.
Similarly a student returning home, even with a negative test should remain 'distant' for the first week.
Quote
"Jon Deeks, a professor of biostatistics at the University of Birmingham, said that the test is ‘entirely unsuitable’ for community testing, such as that planned for university students in the run-up to Christmas. ‘As the test may miss up to half of cases, a negative test result indicates a reduced risk of Covid, but does not exclude Covid,’ Deeks added. ‘This evidence raises serious concerns that the benefits are likely to be few, with serious risk of harm if the public are misled by unjustified government claims of this test’s high performance.’
 Deeks pointed out that the report’s headline figure of 76.8% sensitivity mixes data from different settings. One study of Innova’s device at a testing centre found that the device appeared to miss one out of every two Covid-19 cases (58%). Another study using nurses to test patients suggests it missed one out of every four cases (73%)."
there are more enthusiastic articles and research which i shall add below, but it would seem these tests are a 'guide' and should not be considered definitive -- as with so much Covid info!!

https://www.chemistryworld.com/news/scientists-urge-caution-on-use-of-lateral-flow-tests-to-screen-for-covid-19/4012763.article


this is one of the source papers https://www.bmj.com/content/371/bmj.m4262

and this is a readable extract
https://www.ox.ac.uk/news/2020-11-11-oxford-university-and-phe-confirm-lateral-flow-tests-show-high-specificity-and-are#

this is the more negative evaluation
https://www.bmj.com/content/371/bmj.m4323
63
C19 Notes Database / Light at the End of the Tunnel
« Last post by stog on November 02, 2020, 09:44:12 AM »
Light at the End of the Tunnela paper from the Global Institute , foreword by Tony Blair, that examines some of the options we have as we head into our second UK/EU lockdown

"
Quote
Britain, along with virtually every other country on the continent of Europe, is at an absolutely critical juncture in its response to the Covid-19 pandemic. This paper identifies the vital decisions which need to be taken now.The second wave in terms of cases could be as large or even larger than the first.Britain, like other countries, has taken the decision to go back into lockdown.The essential challenge, which we must meet, is to use November to re-emerge in December with this lockdown being the last.In this paper we suggest that there is a plan involving accelerated deployment of therapeutic drugs and vaccines, mass testing using all available new tests, together with the best data system globally accessible, which would allow us in December to close off resurgence of Covid-19 when we come out of lockdown.At the very least, we raise the questions the government needs urgently to interrogate and answer.The first wave has already had an economic cost roughly three times that of the financial crisis. The consequence of a further round of lockdowns will be devastating.I am optimistic that by the second quarter of next year we will have vaccines and therapeutic drugs which will allow us to manage the disease and return to something like normal.My anxiety is between now and then. We simply can't afford to put our society and economy into severe restrictions for the winter months. The toll in terms of health and the economy will be enormous.





https://institute.global/policy/light-end-tunnel
65
C19 Notes Database / Home management of Covid and Virtual Ward Toolkit
« Last post by stog on November 01, 2020, 02:35:08 PM »
An optimistic post this
so many people worldwide are working on Covid, diagnosis treatment management as well as vaccines etc
i came across this superb initiative today which helps to prevent Hospitals becoming overloaded by means of better diagnosis, treatment and management at home with the use of oximeters - SATS monitors and recording daily levels etc . As a clinical finding of a low sats % is fairly indicative of Covid, I originally was wary that various vulnerables and smokers etc actually function on lower sats levels in their daily lives, so it seemed important that base levels, their normal levels were known, so that there wouldn't be a knee jerk response of Covidity.
Anyhow then i came across these Virtual Ward models which have been piloting so well in the Southampton areas and beyond.
There is a recorded Zoom presentation/webinar (brilliant fella onboard Dr Matt Inada-Kim, Hampshire Hospitals NHS Foundation Trust, presents Covid virtual wards) on this page which will be very useful for Practitioners like ourselves who are currently practising (we are not, but we are still involved with supporting those that are)
The link also has the resources that can be downloaded as well as the latest triage slides being used which help with the latest symptomatology along with clinical signs and findings.
If we were currently working i would be adding SATS readings now as a default to all case histories along with BP and pulse and the myriad of other info we usually record when we examine & Ortho-test on consult and treat.

https://wessexahsn.org.uk/projects/388/covid-oximetry-at-home-toolkit
66
C19 Notes Database / Re: Doctors rethink rush to ventilate
« Last post by stog on November 01, 2020, 01:23:52 PM »
good latest info on case care at home and sats levels within virtual wards
Covid Oximetry at Home Toolkit   Programme(s):
 Covid Oximetry at Home (virtual ward)   

he Covid Oximetry at Home work (sometimes called a "virtual ward") describes an enhanced package of care for individuals with confirmed or suspected Covid-19 who are at risk for future deterioration.

The package of care involves the remote monitoring of the individual's condition through providing regular contact with a local health care team who will reassess the individuals symptoms (including oxygen saturation levels). This close monitoring enables the individual to remain at their usual place of residence whilst allowing early signs of deterioration to be identified and escalated quickly and appropriately.

This material has been designed primarily for use across the South East AHSN network by colleagues within the Wessex AHSN, Kent Surrey Sussex AHSN and Oxford AHSN regions. Colleagues from regions beyond the South East are also very welcome to make use of this toolkit in setting up their own local approaches to remote monitoring.

https://wessexahsn.org.uk/projects/388/covid-oximetry-at-home-toolkit
67
C19 Notes Database / Re: Risk assessment and hygiene for reopening office or Clinic
« Last post by stog on November 01, 2020, 10:22:43 AM »
the swiss cheese respiratory viral pandemic defence


This image highlights that no single intervention is perfect at preventing the spread of a respiratory virus. However, multiple layers of protective approaches will improve success.
 
 Based on the Swiss Cheese Model of Accident Causation by James Reason, this is an adapted version which has been developed by virologist Ian Mackay and colleagues from the University of Queensland.
68
C19 Notes Database / IMMUNE MEMORY IS MORE IMPORTANT
« Last post by stog on October 31, 2020, 09:14:11 AM »
 the following article identifies how, although antibodies may diminish in months, they are not the 'whole story'; how the 'memory response is more important and how some vaccines may better be able to give a long immune memory

IMMUNE MEMORY IS MORE IMPORTANT

"Antibody responses are usually short-lived because once they have done their job you don't need them," said Jonathan Stoye, head of virology at Britain's Francis Crick Institute.

"But that doesn't mean that immunity, either induced by infection or by vaccination, is necessarily short-lived: Memory cells can respond to and combat a new infection."

Since SARS-CoV-2, the virus that causes COVID-19, is a new human virus, scientists don't yet know what levels of immunity will turn out to be protective. But many of the vaccine makers are touting both the antibody and T-cell responses, which are increasingly seen as important to lasting immunity.

"The immune system is very complicated. We know antibodies are important, but they're not the whole story," said Lawrence Young, a professor of molecular oncology at Britain's Warwick University. "The important thing here is immune memory."

Key to the process of immunity are memory cells known as T- and B-lymphocytes. Having made antibodies to a certain virus in an initial infection, the body uses these cells to remember that pathogen, "so when you are next exposed to the virus, the antibody response kicks in much sooner", Young said.

With vaccines, a key feature is that scientists developing them can select as targets the most important bits of the pathogen - in COVID-19's case these include the so-called "spike protein" on the surface of SARS-CoV-2 virus - to get the strongest and most lasting memory responses from T and B lymphocytes.

Some vaccines also contain stimulators or boosters, known as adjuvants, which can supercharge the response, and others are designed to be given in multiple doses to ensure higher concentrations of antibodies will create stronger memories.

"The idea is that while the natural infection may give you poor memory that may not last, the vaccine will give you strong memory that does last," said Danny Altmann, a professor of immunology at Imperial College London.

   https://www.medscape.com/viewarticle/939994
69
C19 Notes Database / Long Covid Definition
« Last post by stog on October 31, 2020, 09:01:09 AM »
Long Covid
UK health bodies have defined the syndrome known as long COVID ahead of developing a new treatment guideline.
The National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of GPs (RCGP) defined post-COVID syndrome as:
"Signs and symptoms that develop during or following an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis. It usually presents with clusters of symptoms, often overlapping, which can fluctuate and change over time and can affect any system in the body.
"Post-COVID-19 syndrome may be considered before 12 weeks while the possibility of an alternative underlying disease is also being assessed."
The scoping document says signs and symptoms can affect different body systems, and can overlap and change over time, including cardiovascular, respiratory, gastrointestinal, neurological, musculoskeletal, metabolic, renal, dermatological, otolaryngological, haematological, and autonomic systems. In addition, patients may have psychiatric problems, generalised pain, fatigue, and persistent fever.
The future guideline, due to be published by the end of the year, will cover specialist referrals, pharmacological and non-pharmacological interventions, and best practices for post-COVID syndrome recovery and rehabilitation services.
It will be a 'living' guideline and subject to updates as new evidence emerges.
 Catch-all Term

It's estimated that as many as 60,000 people in the UK may have long COVID and earlier this month the National Institute for Health Research (NIHR) released a review suggesting it could actually be four syndromes.
In a news release, Paul Chrisp, director of the Centre for Guidelines at NICE, said: "This is a new condition and there is still a lot we don’t know about it. Our aim is that the post-COVID syndrome guideline will begin by setting best practice standards of care based on the current evidence but, as our understanding of the condition grows, be adaptable and responsive to new evidence as it emerges."
Safia Qureshi, director of evidence for Healthcare Improvement Scotland, said: "The scope report is a first and vital stage in the production of a guideline which aims to identify symptoms and outline treatment options. We’re delighted to work with NICE and the RCGP on this important piece of work."
RCGP Chair Professor Martin Marshall, said: "Before we can effectively diagnose, treat and manage a condition, we need to know what we're dealing with, so it’s encouraging to be making such rapid progress in this regard as we work with NICE and SIGN to develop this important guidance."
He added: "Now that we are clear about its scope, we can move forward in developing guidance, based on the latest evidence, to support GPs to deliver the most appropriate care and support to patients suffering with the long-term effects of COVID-19 in the community. This guidance will need to evolve as our understanding of the condition grows through clinical experience and robust research."

https://www.medscape.com/viewarticle/940067
70
C19 Notes Database / Re: Risk assessment and hygiene for reopening office or Clinic
« Last post by stog on October 29, 2020, 04:34:54 PM »
excellent graphic displays of aerosol and ventilation in enclosed spaces with differing contact times and use of ventilation



https://english.elpais.com/society/2020-10-28/a-room-a-bar-and-a-class-how-the-coronavirus-is-spread-through-the-air.html
Pages: 1 ... 5 6 7 8 9 10